Loading...

Alan M Fogelman

Title(s)Professor, Medicine
SchoolMedicine
Address760 Westwood Plaza 32-144
Los Angeles CA 90024
Phone3108256058
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Targeting the Enterocyte to Prevent Vascular Inflammation
    NIH/NHLBI R01HL148286Jun 1, 2019 - May 31, 2023
    Role: Principal Investigator
    Lipid and Lipoprotein Metabolism in Atherosclerosis
    NIH/NHLBI P01HL030568Aug 1, 1997 - Mar 31, 2014
    Role: Principal Investigator
    GORDON RESEARCH CONFERENCE ON ATHEROSCLEROSIS 1989
    NIH/NHLBI R13HL042904Jun 18, 1989 - Jun 17, 1990
    Role: Principal Investigator
    PATHOPHYSIOLOGY OF MYOCARDIAL DISEASE
    NIH/NHLBI T32HL007412Jul 1, 1978 - Jun 30, 1994
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. The role of the small intestine in modulating metabolism and inflammation in atherosclerosis and cancer. Curr Opin Lipidol. 2019 10; 30(5):383-387. Mukherjee P, Chattopadhyay A, Fogelman AM. PMID: 31356236.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    2. Noggin depletion in adipocytes promotes obesity in mice. Mol Metab. 2019 07; 25:50-63. Blázquez-Medela AM, Jumabay M, Rajbhandari P, Sallam T, Guo Y, Yao J, Vergnes L, Reue K, Zhang L, Yao Y, Fogelman AM, Tontonoz P, Lusis AJ, Wu X, Boström KI. PMID: 31027994.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    3. Paraoxonase 2 protects against acute myocardial ischemia-reperfusion injury by modulating mitochondrial function and oxidative stress via the PI3K/Akt/GSK-3ß RISK pathway. J Mol Cell Cardiol. 2019 04; 129:154-164. Sulaiman D, Li J, Devarajan A, Cunningham CM, Li M, Fishbein GA, Fogelman AM, Eghbali M, Reddy ST. PMID: 30802459.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCells
    4. PON2 Deficiency Leads to Increased Susceptibility to Diet-Induced Obesity. Antioxidants (Basel). 2019 Jan 11; 8(1). Shih DM, Meng Y, Sallam T, Vergnes L, Shu ML, Reue K, Tontonoz P, Fogelman AM, Lusis AJ, Reddy ST. PMID: 30641857.
      View in: PubMed   Mentions:
    5. Treating the Intestine with Oral ApoA-I Mimetic Tg6F Reduces Tumor Burden in Mouse Models of Metastatic Lung Cancer. Sci Rep. 2018 06 13; 8(1):9032. Chattopadhyay A, Yang X, Mukherjee P, Sulaiman D, Fogelman HR, Grijalva V, Dubinett S, Wasler TC, Paul MK, Salehi-Rad R, Mack JJ, Iruela-Arispe ML, Navab M, Fogelman AM, Reddy ST. PMID: 29899427.
      View in: PubMed   Mentions: 3     Fields:    Translation:AnimalsCells
    6. Paraoxonase 2 overexpression inhibits tumor development in a mouse model of ovarian cancer. Cell Death Dis. 2018 03 12; 9(3):392. Devarajan A, Su F, Grijalva V, Yalamanchi M, Yalamanchi A, Gao F, Trost H, Nwokedi J, Farias-Eisner G, Farias-Eisner R, Fogelman AM, Reddy ST. PMID: 29531225.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    7. Phospholipid Remodeling and Cholesterol Availability Regulate Intestinal Stemness and Tumorigenesis. Cell Stem Cell. 2018 02 01; 22(2):206-220.e4. Wang B, Rong X, Palladino END, Wang J, Fogelman AM, Martín MG, Alrefai WA, Ford DA, Tontonoz P. PMID: 29395055.
      View in: PubMed   Mentions: 23     Fields:    Translation:AnimalsCells
    8. Making sense of a seemingly odd connection. Eur Heart J. 2017 12 21; 38(48):3588-3589. Fogelman AM, Reddy ST. PMID: 29020393.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. NOTCH1 is a mechanosensor in adult arteries. Nat Commun. 2017 11 20; 8(1):1620. Mack JJ, Mosqueiro TS, Archer BJ, Jones WM, Sunshine H, Faas GC, Briot A, Aragón RL, Su T, Romay MC, McDonald AI, Kuo CH, Lizama CO, Lane TF, Zovein AC, Fang Y, Tarling EJ, de Aguiar Vallim TQ, Navab M, Fogelman AM, Bouchard LS, Iruela-Arispe ML. PMID: 29158473.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansAnimalsCells
    10. Vascular endothelium plays a key role in directing pulmonary epithelial cell differentiation. J Cell Biol. 2017 10 02; 216(10):3369-3385. Yao J, Guihard PJ, Wu X, Blazquez-Medela AM, Spencer MJ, Jumabay M, Tontonoz P, Fogelman AM, Boström KI, Yao Y. PMID: 28838957.
      View in: PubMed   Mentions: 3     Fields:    Translation:AnimalsCells
    11. Transgenic tomatoes expressing the 6F peptide and ezetimibe prevent diet-induced increases of IFN-ß and cholesterol 25-hydroxylase in jejunum. J Lipid Res. 2017 08; 58(8):1636-1647. Mukherjee P, Hough G, Chattopadhyay A, Navab M, Fogelman HR, Meriwether D, Williams K, Bensinger S, Moller T, Faull KF, Lusis AJ, Iruela-Arispe ML, Bostrom KI, Tontonoz P, Reddy ST, Fogelman AM. PMID: 28592401.
      View in: PubMed   Mentions: 4     Fields:    Translation:Animals
    12. Combined effects of bone morphogenetic protein 10 and crossveinless-2 on cardiomyocyte differentiation in mouse adipocyte-derived stem cells. J Cell Physiol. 2018 Mar; 233(3):1812-1822. Jumabay M, Zhumabai J, Mansurov N, Niklason KC, Guihard PJ, Cubberly MR, Fogelman AM, Iruela-Arispe L, Yao Y, Saparov A, Boström KI. PMID: 28464239.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCells
    13. Ambient Ultrafine Particle Ingestion Alters Gut Microbiota in Association with Increased Atherogenic Lipid Metabolites. Sci Rep. 2017 02 17; 7:42906. Li R, Yang J, Saffari A, Jacobs J, Baek KI, Hough G, Larauche MH, Ma J, Jen N, Moussaoui N, Zhou B, Kang H, Reddy S, Henning SM, Campen MJ, Pisegna J, Li Z, Fogelman AM, Sioutas C, Navab M, Hsiai TK. PMID: 28211537.
      View in: PubMed   Mentions: 10     Fields:    Translation:AnimalsCells
    14. Transintestinal transport of the anti-inflammatory drug 4F and the modulation of transintestinal cholesterol efflux. J Lipid Res. 2016 07; 57(7):1175-93. Meriwether D, Sulaiman D, Wagner A, Grijalva V, Kaji I, Williams KJ, Yu L, Fogelman S, Volpe C, Bensinger SJ, Anantharamaiah GM, Shechter I, Fogelman AM, Reddy ST. PMID: 27199144.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    15. Apolipoprotein E-/- Mice Lacking Hemopexin Develop Increased Atherosclerosis via Mechanisms That Include Oxidative Stress and Altered Macrophage Function. Arterioscler Thromb Vasc Biol. 2016 06; 36(6):1152-63. Mehta NU, Grijalva V, Hama S, Wagner A, Navab M, Fogelman AM, Reddy ST. PMID: 27079878.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    16. Tg6F ameliorates the increase in oxidized phospholipids in the jejunum of mice fed unsaturated LysoPC or WD. J Lipid Res. 2016 05; 57(5):832-47. Chattopadhyay A, Navab M, Hough G, Grijalva V, Mukherjee P, Fogelman HR, Hwang LH, Faull KF, Lusis AJ, Reddy ST, Fogelman AM. PMID: 26965826.
      View in: PubMed   Mentions: 10     Fields:    Translation:AnimalsCells
    17. Carboxyl-Terminal Cleavage of Apolipoprotein A-I by Human Mast Cell Chymase Impairs Its Anti-Inflammatory Properties. Arterioscler Thromb Vasc Biol. 2016 Feb; 36(2):274-84. Nguyen SD, Maaninka K, Lappalainen J, Nurmi K, Metso J, Öörni K, Navab M, Fogelman AM, Jauhiainen M, Lee-Rueckert M, Kovanen PT. PMID: 26681753.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    18. Proinflammatory high-density lipoprotein results from oxidized lipid mediators in the pathogenesis of both idiopathic and associated types of pulmonary arterial hypertension. Pulm Circ. 2015 Dec; 5(4):640-8. Ross DJ, Hough G, Hama S, Aboulhosn J, Belperio JA, Saggar R, Van Lenten BJ, Ardehali A, Eghbali M, Reddy S, Fogelman AM, Navab M. PMID: 26697171.
      View in: PubMed   Mentions:
    19. Further evidence that high-density lipoprotein is a chameleon-like lipoprotein. Eur Heart J. 2015 Nov 14; 36(43):3017-9. Fogelman AM. PMID: 26377399.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    20. Efficacy of tomato concentrates in mouse models of dyslipidemia and cancer. Pharmacol Res Perspect. 2015 Aug; 3(4):e00154. Chattopadhyay A, Grijalva V, Hough G, Su F, Mukherjee P, Farias-Eisner R, Anantharamaiah GM, Faull KF, Hwang LH, Navab M, Fogelman AM, Reddy ST. PMID: 26171234.
      View in: PubMed   Mentions: 7     Fields:    
    21. Source and role of intestinally derived lysophosphatidic acid in dyslipidemia and atherosclerosis. J Lipid Res. 2015 Apr; 56(4):871-87. Navab M, Chattopadhyay A, Hough G, Meriwether D, Fogelman SI, Wagner AC, Grijalva V, Su F, Anantharamaiah GM, Hwang LH, Faull KF, Reddy ST, Fogelman AM. PMID: 25646365.
      View in: PubMed   Mentions: 16     Fields:    Translation:Animals
    22. TMAO is both a biomarker and a renal toxin. Circ Res. 2015 Jan 30; 116(3):396-7. Fogelman AM. PMID: 25634968.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimals
    23. Effect of exposure to atmospheric ultrafine particles on production of free fatty acids and lipid metabolites in the mouse small intestine. Environ Health Perspect. 2015 Jan; 123(1):34-41. Li R, Navab K, Hough G, Daher N, Zhang M, Mittelstein D, Lee K, Pakbin P, Saffari A, Bhetraratana M, Sulaiman D, Beebe T, Wu L, Jen N, Wine E, Tseng CH, Araujo JA, Fogelman A, Sioutas C, Navab M, Hsiai TK. PMID: 25170928.
      View in: PubMed   Mentions: 14     Fields:    Translation:AnimalsPHPublic Health
    24. Apolipoprotein A-I mimetics. Curr Opin Lipidol. 2014 Aug; 25(4):304-8. Reddy ST, Navab M, Anantharamaiah GM, Fogelman AM. PMID: 24977978.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimals
    25. Apolipoprotein A-I mimetic peptide 4F rescues pulmonary hypertension by inducing microRNA-193-3p. Circulation. 2014 Aug 26; 130(9):776-85. Sharma S, Umar S, Potus F, Iorga A, Wong G, Meriwether D, Breuils-Bonnet S, Mai D, Navab K, Ross D, Navab M, Provencher S, Fogelman AM, Bonnet S, Reddy ST, Eghbali M. PMID: 24963038.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansAnimalsCells
    26. Trying to harness the potential of HDL: wishful thinking or sound strategy? Eur Heart J. 2014 Dec 07; 35(46):3248-9. Fogelman AM. PMID: 24818600.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    27. High-density lipoprotein: vascular protective effects, dysfunction, and potential as therapeutic target. Circ Res. 2014 Jan 03; 114(1):171-82. Lüscher TF, Landmesser U, von Eckardstein A, Fogelman AM. PMID: 24385510.
      View in: PubMed   Mentions: 58     Fields:    Translation:HumansAnimals
    28. Protection against ischemia/reperfusion injury by high-density lipoprotein and its components. Circ Res. 2013 Dec 06; 113(12):1281-2. Fogelman AM, Reddy ST, Navab M. PMID: 24311615.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    29. Transgenic 6F tomatoes act on the small intestine to prevent systemic inflammation and dyslipidemia caused by Western diet and intestinally derived lysophosphatidic acid. J Lipid Res. 2013 Dec; 54(12):3403-18. Navab M, Hough G, Buga GM, Su F, Wagner AC, Meriwether D, Chattopadhyay A, Gao F, Grijalva V, Danciger JS, Van Lenten BJ, Org E, Lusis AJ, Pan C, Anantharamaiah GM, Farias-Eisner R, Smyth SS, Reddy ST, Fogelman AM. PMID: 24085744.
      View in: PubMed   Mentions: 26     Fields:    Translation:Animals
    30. Heart failure is associated with impaired anti-inflammatory and antioxidant properties of high-density lipoproteins. Am J Cardiol. 2013 Dec 01; 112(11):1770-7. Kim JB, Hama S, Hough G, Navab M, Fogelman AM, Maclellan WR, Horwich TB, Fonarow GC. PMID: 24050409.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    31. Ambient ultrafine particles alter lipid metabolism and HDL anti-oxidant capacity in LDLR-null mice. J Lipid Res. 2013 Jun; 54(6):1608-15. Li R, Navab M, Pakbin P, Ning Z, Navab K, Hough G, Morgan TE, Finch CE, Araujo JA, Fogelman AM, Sioutas C, Hsiai T. PMID: 23564731.
      View in: PubMed   Mentions: 26     Fields:    Translation:AnimalsCells
    32. Diesel exhaust induces systemic lipid peroxidation and development of dysfunctional pro-oxidant and pro-inflammatory high-density lipoprotein. Arterioscler Thromb Vasc Biol. 2013 Jun; 33(6):1153-61. Yin F, Lawal A, Ricks J, Fox JR, Larson T, Navab M, Fogelman AM, Rosenfeld ME, Araujo JA. PMID: 23559632.
      View in: PubMed   Mentions: 43     Fields:    Translation:AnimalsCellsPHPublic Health
    33. A novel approach to oral apoA-I mimetic therapy. J Lipid Res. 2013 Apr; 54(4):995-1010. Chattopadhyay A, Navab M, Hough G, Gao F, Meriwether D, Grijalva V, Springstead JR, Palgnachari MN, Namiri-Kalantari R, Su F, Van Lenten BJ, Wagner AC, Anantharamaiah GM, Farias-Eisner R, Farias-Eisener R, Reddy ST, Fogelman AM. PMID: 23378594.
      View in: PubMed   Mentions: 27     Fields:    Translation:Animals
    34. High-density lipoprotein and 4F peptide reduce systemic inflammation by modulating intestinal oxidized lipid metabolism: novel hypotheses and review of literature. Arterioscler Thromb Vasc Biol. 2012 Nov; 32(11):2553-60. Navab M, Reddy ST, Van Lenten BJ, Buga GM, Hough G, Wagner AC, Fogelman AM. PMID: 23077141.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansAnimalsCells
    35. Effects of lipid-probe interactions in biochemical fluorometric methods that assess HDL redox activity. Lipids Health Dis. 2012 Jul 06; 11:87. Kelesidis T, Reddy ST, Huynh D, Meriwether D, Fogelman AM, Navab M, Yang OO. PMID: 22768920.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    36. Apolipoprotein A-I mimetic peptides inhibit expression and activity of hypoxia-inducible factor-1a in human ovarian cancer cell lines and a mouse ovarian cancer model. J Pharmacol Exp Ther. 2012 Aug; 342(2):255-62. Gao F, Chattopadhyay A, Navab M, Grijalva V, Su F, Fogelman AM, Reddy ST, Farias-Eisner R. PMID: 22537771.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimalsCells
    37. LXRa is uniquely required for maximal reverse cholesterol transport and atheroprotection in ApoE-deficient mice. J Lipid Res. 2012 Jun; 53(6):1126-33. Hong C, Bradley MN, Rong X, Wang X, Wagner A, Grijalva V, Castellani LW, Salazar J, Realegeno S, Boyadjian R, Fogelman AM, Van Lenten BJ, Reddy ST, Lusis AJ, Tangirala RK, Tontonoz P. PMID: 22454476.
      View in: PubMed   Mentions: 15     Fields:    Translation:AnimalsCells
    38. HDL mimetics inhibit tumor development in both induced and spontaneous mouse models of colon cancer. Mol Cancer Ther. 2012 Jun; 11(6):1311-9. Su F, Grijalva V, Navab K, Ganapathy E, Meriwether D, Imaizumi S, Navab M, Fogelman AM, Reddy ST, Farias-Eisner R. PMID: 22416044.
      View in: PubMed   Mentions: 29     Fields:    Translation:AnimalsCells
    39. D-4F-mediated reduction in metabolites of arachidonic and linoleic acids in the small intestine is associated with decreased inflammation in low-density lipoprotein receptor-null mice. J Lipid Res. 2012 Mar; 53(3):437-45. Navab M, Reddy ST, Anantharamaiah GM, Hough G, Buga GM, Danciger J, Fogelman AM. PMID: 22167743.
      View in: PubMed   Mentions: 30     Fields:    Translation:Animals
    40. A biochemical fluorometric method for assessing the oxidative properties of HDL. J Lipid Res. 2011 Dec; 52(12):2341-51. Kelesidis T, Currier JS, Huynh D, Meriwether D, Charles-Schoeman C, Reddy ST, Fogelman AM, Navab M, Yang OO. PMID: 21957198.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansAnimalsCells
    41. Enhancement by LDL of transfer of L-4F and oxidized lipids to HDL in C57BL/6J mice and human plasma. J Lipid Res. 2011 Oct; 52(10):1795-809. Meriwether D, Imaizumi S, Grijalva V, Hough G, Vakili L, Anantharamaiah GM, Farias-Eisner R, Navab M, Fogelman AM, Reddy ST, Shechter I. PMID: 21804067.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimalsCells
    42. Dysfunctional high-density lipoprotein and the potential of apolipoprotein A-1 mimetic peptides to normalize the composition and function of lipoproteins. Circ J. 2011; 75(7):1533-8. Imaizumi S, Navab M, Morgantini C, Charles-Schoeman C, Su F, Gao F, Kwon M, Ganapathy E, Meriwether D, Farias-Eisner R, Fogelman AM, Reddy ST. PMID: 21628835.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimals
    43. D-4F, an apoA-I mimetic peptide, inhibits proliferation and tumorigenicity of epithelial ovarian cancer cells by upregulating the antioxidant enzyme MnSOD. Int J Cancer. 2012 Mar 01; 130(5):1071-81. Ganapathy E, Su F, Meriwether D, Devarajan A, Grijalva V, Gao F, Chattopadhyay A, Anantharamaiah GM, Navab M, Fogelman AM, Reddy ST, Farias-Eisner R. PMID: 21425255.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansAnimalsCells
    44. Intestine may be a major site of action for the apoA-I mimetic peptide 4F whether administered subcutaneously or orally. J Lipid Res. 2011 Jun; 52(6):1200-10. Navab M, Reddy ST, Anantharamaiah GM, Imaizumi S, Hough G, Hama S, Fogelman AM. PMID: 21444758.
      View in: PubMed   Mentions: 35     Fields:    Translation:AnimalsCells
    45. HIV-1 infected patients with suppressed plasma viremia on treatment have pro-inflammatory HDL. Lipids Health Dis. 2011 Feb 23; 10:35. Kelesidis T, Yang OO, Currier JS, Navab K, Fogelman AM, Navab M. PMID: 21345230.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    46. HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms. Nat Rev Cardiol. 2011 Apr; 8(4):222-32. Navab M, Reddy ST, Van Lenten BJ, Fogelman AM. PMID: 21304474.
      View in: PubMed   Mentions: 153     Fields:    Translation:Humans
    47. L-5F, an apolipoprotein A-I mimetic, inhibits tumor angiogenesis by suppressing VEGF/basic FGF signaling pathways. Integr Biol (Camb). 2011 Apr; 3(4):479-89. Gao F, Vasquez SX, Su F, Roberts S, Shah N, Grijalva V, Imaizumi S, Chattopadhyay A, Ganapathy E, Meriwether D, Johnston B, Anantharamaiah GM, Navab M, Fogelman AM, Reddy ST, Farias-Eisner R. PMID: 21283904.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansAnimalsCells
    48. Apolipoprotein A-I (apoA-I) and apoA-I mimetic peptides inhibit tumor development in a mouse model of ovarian cancer. Proc Natl Acad Sci U S A. 2010 Nov 16; 107(46):19997-20002. Su F, Kozak KR, Imaizumi S, Gao F, Amneus MW, Grijalva V, Ng C, Wagner A, Hough G, Farias-Eisner G, Anantharamaiah GM, Van Lenten BJ, Navab M, Fogelman AM, Reddy ST, Farias-Eisner R. PMID: 21041624.
      View in: PubMed   Mentions: 74     Fields:    Translation:HumansAnimalsCells
    49. L-4F differentially alters plasma levels of oxidized fatty acids resulting in more anti-inflammatory HDL in mice. Drug Metab Lett. 2010 Aug; 4(3):139-48. Imaizumi S, Grijalva V, Navab M, Van Lenten BJ, Wagner AC, Anantharamiah GM, Fogelman AM, Reddy ST. PMID: 20642447.
      View in: PubMed   Mentions: 30     Fields:    Translation:AnimalsCells
    50. Mitogen-activated protein kinase phosphatase-1 deficiency decreases atherosclerosis in apolipoprotein E null mice by reducing monocyte chemoattractant protein-1 levels. Mol Genet Metab. 2010 Sep; 101(1):66-75. Imaizumi S, Grijalva V, Priceman S, Wu L, Su F, Farias-Eisner R, Hama S, Navab M, Fogelman AM, Reddy ST. PMID: 20619710.
      View in: PubMed   Mentions: 7     Fields:    Translation:AnimalsCells
    51. Treatment with apolipoprotein A-1 mimetic peptide reduces lupus-like manifestations in a murine lupus model of accelerated atherosclerosis. Arthritis Res Ther. 2010; 12(3):R93. Woo JM, Lin Z, Navab M, Van Dyck C, Trejo-Lopez Y, Woo KM, Li H, Castellani LW, Wang X, Iikuni N, Rullo OJ, Wu H, La Cava A, Fogelman AM, Lusis AJ, Tsao BP. PMID: 20482780.
      View in: PubMed   Mentions: 20     Fields:    Translation:Animals
    52. Oxpholipin 11D: an anti-inflammatory peptide that binds cholesterol and oxidized phospholipids. PLoS One. 2010 Apr 14; 5(4):e10181. Ruchala P, Navab M, Jung CL, Hama-Levy S, Micewicz ED, Luong H, Reyles JE, Sharma S, Waring AJ, Fogelman AM, Lehrer RI. PMID: 20418958.
      View in: PubMed   Mentions: 3     Fields:    Translation:Cells
    53. L-4F alters hyperlipidemic (but not healthy) mouse plasma to reduce platelet aggregation. Arterioscler Thromb Vasc Biol. 2010 Feb; 30(2):283-9. Buga GM, Navab M, Imaizumi S, Reddy ST, Yekta B, Hough G, Chanslor S, Anantharamaiah GM, Fogelman AM. PMID: 19965777.
      View in: PubMed   Mentions: 16     Fields:    Translation:AnimalsCells
    54. HDL as a biomarker, potential therapeutic target, and therapy. Diabetes. 2009 Dec; 58(12):2711-7. Navab M, Anantharamaiah GM, Reddy ST, Van Lenten BJ, Fogelman AM. PMID: 19940234.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansAnimalsCells
    55. Abnormal function of high-density lipoprotein is associated with poor disease control and an altered protein cargo in rheumatoid arthritis. Arthritis Rheum. 2009 Oct; 60(10):2870-9. Charles-Schoeman C, Watanabe J, Lee YY, Furst DE, Amjadi S, Elashoff D, Park G, McMahon M, Paulus HE, Fogelman AM, Reddy ST. PMID: 19790070.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    56. Structure and function of HDL mimetics. Arterioscler Thromb Vasc Biol. 2010 Feb; 30(2):164-8. Navab M, Shechter I, Anantharamaiah GM, Reddy ST, Van Lenten BJ, Fogelman AM. PMID: 19608977.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansAnimalsCells
    57. A novel method for oral delivery of apolipoprotein mimetic peptides synthesized from all L-amino acids. J Lipid Res. 2009 Aug; 50(8):1538-47. Navab M, Ruchala P, Waring AJ, Lehrer RI, Hama S, Hough G, Palgunachari MN, Anantharamaiah GM, Fogelman AM. PMID: 19225094.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansAnimalsCells
    58. Apolipoprotein A-I mimetic peptides. Curr Atheroscler Rep. 2009 Jan; 11(1):52-7. Van Lenten BJ, Wagner AC, Anantharamaiah GM, Navab M, Reddy ST, Buga GM, Fogelman AM. PMID: 19080728.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansAnimals
    59. Multiple indications for anti-inflammatory apolipoprotein mimetic peptides. Curr Opin Investig Drugs. 2008 Nov; 9(11):1157-62. Van Lenten BJ, Navab M, Anantharamaiah GM, Buga GM, Reddy ST, Fogelman AM. PMID: 18951294.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimals
    60. The role of dysfunctional HDL in atherosclerosis. J Lipid Res. 2009 Apr; 50 Suppl:S145-9. Navab M, Reddy ST, Van Lenten BJ, Anantharamaiah GM, Fogelman AM. PMID: 18955731.
      View in: PubMed   Mentions: 61     Fields:    Translation:HumansAnimalsCells
    61. Is it just paraoxonase 1 or are other members of the paraoxonase gene family implicated in atherosclerosis? Curr Opin Lipidol. 2008 Aug; 19(4):405-8. Reddy ST, Devarajan A, Bourquard N, Shih D, Fogelman AM. PMID: 18607188.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansAnimals
    62. Host-derived oxidized phospholipids and HDL regulate innate immunity in human leprosy. J Clin Invest. 2008 Aug; 118(8):2917-28. Cruz D, Watson AD, Miller CS, Montoya D, Ochoa MT, Sieling PA, Gutierrez MA, Navab M, Reddy ST, Witztum JL, Fogelman AM, Rea TH, Eisenberg D, Berliner J, Modlin RL. PMID: 18636118.
      View in: PubMed   Mentions: 63     Fields:    Translation:HumansCells
    63. Anti-inflammatory apoA-I-mimetic peptides bind oxidized lipids with much higher affinity than human apoA-I. J Lipid Res. 2008 Nov; 49(11):2302-11. Van Lenten BJ, Wagner AC, Jung CL, Ruchala P, Waring AJ, Lehrer RI, Watson AD, Hama S, Navab M, Anantharamaiah GM, Fogelman AM. PMID: 18621920.
      View in: PubMed   Mentions: 86     Fields:    Translation:HumansCells
    64. Treatment with an apolipoprotein A-1 mimetic peptide in combination with pravastatin inhibits collagen-induced arthritis. Clin Immunol. 2008 May; 127(2):234-44. Charles-Schoeman C, Banquerigo ML, Hama S, Navab M, Park GS, Van Lenten BJ, Wagner AC, Fogelman AM, Brahn E. PMID: 18337176.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansAnimalsCells
    65. Apo A-1 mimetic peptides as atheroprotective agents in murine models. Curr Drug Targets. 2008 Mar; 9(3):204-9. Navab M, Anantharamaiah GM, Reddy ST, Van Lenten BJ, Fogelman AM. PMID: 18336238.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsCells
    66. The effect of apolipoprotein mimetic peptides in inflammatory disorders other than atherosclerosis. Trends Cardiovasc Med. 2008 Feb; 18(2):61-6. Navab M, Anantharamaiah GM, Fogelman AM. PMID: 18308197.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansAnimalsCells
    67. D-4F reduces EO6 immunoreactivity, SREBP-1c mRNA levels, and renal inflammation in LDL receptor-null mice fed a Western diet. J Lipid Res. 2008 Jan; 49(1):192-205. Buga GM, Frank JS, Mottino GA, Hakhamian A, Narasimha A, Watson AD, Yekta B, Navab M, Reddy ST, Anantharamaiah GM, Fogelman AM. PMID: 17925450.
      View in: PubMed   Mentions: 24     Fields:    Translation:AnimalsCells
    68. Lipoprotein inflammatory properties and serum amyloid A levels but not cholesterol levels predict lesion area in cholesterol-fed rabbits. J Lipid Res. 2007 Nov; 48(11):2344-53. Van Lenten BJ, Wagner AC, Navab M, Anantharamaiah GM, Hama S, Reddy ST, Fogelman AM. PMID: 17693626.
      View in: PubMed   Mentions: 57     Fields:    Translation:AnimalsCells
    69. The paradox of dysfunctional high-density lipoprotein. Curr Opin Lipidol. 2007 Aug; 18(4):427-34. Ansell BJ, Fonarow GC, Fogelman AM. PMID: 17620860.
      View in: PubMed   Mentions: 59     Fields:    Translation:Humans
    70. Effects of high-dose atorvastatin on antiinflammatory properties of high density lipoprotein in patients with rheumatoid arthritis: a pilot study. J Rheumatol. 2007 Jul; 34(7):1459-64. Charles-Schoeman C, Khanna D, Furst DE, McMahon M, Reddy ST, Fogelman AM, Paulus HE, Park GS, Gong T, Ansell BJ. PMID: 17552046.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    71. Peptide Mimetics of Apolipoproteins Improve HDL Function. J Clin Lipidol. 2007 May; 1(2):142-7. Navab M, Anantharamaiah GM, Reddy ST, Van Lenten BJ, Buga GM, Fogelman AM. PMID: 18449337.
      View in: PubMed   Mentions: 5     Fields:    
    72. Adenovirus-mediated expression of human paraoxonase 3 protects against the progression of atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol. 2007 Jun; 27(6):1368-74. Ng CJ, Bourquard N, Hama SY, Shih D, Grijalva VR, Navab M, Fogelman AM, Reddy ST. PMID: 17446441.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansAnimalsCells
    73. Decreased obesity and atherosclerosis in human paraoxonase 3 transgenic mice. Circ Res. 2007 Apr 27; 100(8):1200-7. Shih DM, Xia YR, Wang XP, Wang SS, Bourquard N, Fogelman AM, Lusis AJ, Reddy ST. PMID: 17379834.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansAnimals
    74. Modifying the anti-inflammatory effects of high-density lipoprotein. Curr Atheroscler Rep. 2007 Jan; 9(1):57-63. Ansell BJ, Fonarow GC, Navab M, Fogelman AM. PMID: 17169248.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    75. Apolipoprotein A-I mimetic peptides and their role in atherosclerosis prevention. Nat Clin Pract Cardiovasc Med. 2006 Oct; 3(10):540-7. Navab M, Anantharamaiah GM, Reddy ST, Fogelman AM. PMID: 16990839.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansAnimalsCells
    76. Mechanisms of disease: proatherogenic HDL--an evolving field. Nat Clin Pract Endocrinol Metab. 2006 Sep; 2(9):504-11. Navab M, Anantharamaiah GM, Reddy ST, Van Lenten BJ, Ansell BJ, Fogelman AM. PMID: 16957764.
      View in: PubMed   Mentions: 65     Fields:    Translation:HumansAnimals
    77. High-density lipoprotein: is it always atheroprotective? Curr Atheroscler Rep. 2006 Sep; 8(5):405-11. Ansell BJ, Fonarow GC, Fogelman AM. PMID: 16901411.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    78. Paraoxonase-2 deficiency aggravates atherosclerosis in mice despite lower apolipoprotein-B-containing lipoproteins: anti-atherogenic role for paraoxonase-2. J Biol Chem. 2006 Oct 06; 281(40):29491-500. Ng CJ, Bourquard N, Grijalva V, Hama S, Shih DM, Navab M, Fogelman AM, Lusis AJ, Young S, Reddy ST. PMID: 16891303.
      View in: PubMed   Mentions: 47     Fields:    Translation:AnimalsCells
    79. Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum. 2006 Aug; 54(8):2541-9. McMahon M, Grossman J, FitzGerald J, Dahlin-Lee E, Wallace DJ, Thong BY, Badsha H, Kalunian K, Charles C, Navab M, Fogelman AM, Hahn BH. PMID: 16868975.
      View in: PubMed   Mentions: 106     Fields:    Translation:HumansCells
    80. Potential clinical utility of high-density lipoprotein-mimetic peptides. Curr Opin Lipidol. 2006 Aug; 17(4):440-4. Navab M, Anantharamaiah GM, Reddy ST, Van Lenten BJ, Datta G, Garber D, Fogelman AM. PMID: 16832169.
      View in: PubMed   Mentions: 4     Fields:    Translation:Animals
    81. D-4F decreases brain arteriole inflammation and improves cognitive performance in LDL receptor-null mice on a Western diet. J Lipid Res. 2006 Oct; 47(10):2148-60. Buga GM, Frank JS, Mottino GA, Hendizadeh M, Hakhamian A, Tillisch JH, Reddy ST, Navab M, Anantharamaiah GM, Ignarro LJ, Fogelman AM. PMID: 16835442.
      View in: PubMed   Mentions: 26     Fields:    Translation:Animals
    82. Oral amphipathic peptides as therapeutic agents. Expert Opin Investig Drugs. 2006 Jan; 15(1):13-21. Reddy ST, Anantharamaiah GM, Navab M, Hama S, Hough G, Grijalva V, Garber DW, Datta G, Fogelman AM. PMID: 16370930.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    83. An apolipoprotein A-I mimetic works best in the presence of apolipoprotein A-I. Circ Res. 2005 Nov 25; 97(11):1085-6. Navab M, Anantharamaiah GM, Fogelman AM. PMID: 16306451.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimals
    84. High-density lipoprotein function recent advances. J Am Coll Cardiol. 2005 Nov 15; 46(10):1792-8. Ansell BJ, Watson KE, Fogelman AM, Navab M, Fonarow GC. PMID: 16286161.
      View in: PubMed   Mentions: 51     Fields:    Translation:HumansAnimalsCells
    85. Oral small peptides render HDL antiinflammatory in mice and monkeys and reduce atherosclerosis in ApoE null mice. Circ Res. 2005 Sep 16; 97(6):524-32. Navab M, Anantharamaiah GM, Reddy ST, Hama S, Hough G, Frank JS, Grijalva VR, Ganesh VK, Mishra VK, Palgunachari MN, Fogelman AM. PMID: 16100046.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansAnimalsCells
    86. An oral apoJ peptide renders HDL antiinflammatory in mice and monkeys and dramatically reduces atherosclerosis in apolipoprotein E-null mice. Arterioscler Thromb Vasc Biol. 2005 Sep; 25(9):1932-7. Navab M, Anantharamaiah GM, Reddy ST, Van Lenten BJ, Wagner AC, Hama S, Hough G, Bachini E, Garber DW, Mishra VK, Palgunachari MN, Fogelman AM. PMID: 15961700.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansAnimalsCells
    87. The role of high-density lipoprotein in inflammation. Trends Cardiovasc Med. 2005 May; 15(4):158-61. Navab M, Anantharamaiah GM, Fogelman AM. PMID: 16099381.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansAnimals
    88. D-4F and statins synergize to render HDL antiinflammatory in mice and monkeys and cause lesion regression in old apolipoprotein E-null mice. Arterioscler Thromb Vasc Biol. 2005 Jul; 25(7):1426-32. Navab M, Anantharamaiah GM, Hama S, Hough G, Reddy ST, Frank JS, Garber DW, Handattu S, Fogelman AM. PMID: 15845909.
      View in: PubMed   Mentions: 56     Fields:    Translation:AnimalsCells
    89. Apolipoprotein A-I mimetic peptides. Arterioscler Thromb Vasc Biol. 2005 Jul; 25(7):1325-31. Navab M, Anantharamaiah GM, Reddy ST, Hama S, Hough G, Grijalva VR, Yu N, Ansell BJ, Datta G, Garber DW, Fogelman AM. PMID: 15831812.
      View in: PubMed   Mentions: 76     Fields:    Translation:HumansAnimalsCells
    90. The double jeopardy of HDL. Ann Med. 2005; 37(3):173-8. Navab M, Ananthramaiah GM, Reddy ST, Van Lenten BJ, Ansell BJ, Hama S, Hough G, Bachini E, Grijalva VR, Wagner AC, Shaposhnik Z, Fogelman AM. PMID: 16019715.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansAnimals
    91. Anti-inflammatory properties of HDL. Rev Endocr Metab Disord. 2004 Dec; 5(4):351-8. Ansell BJ, Navab M, Watson KE, Fonarow GC, Fogelman AM. PMID: 15486468.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimalsCells
    92. Human apolipoprotein A-I and A-I mimetic peptides: potential for atherosclerosis reversal. Curr Opin Lipidol. 2004 Dec; 15(6):645-9. Navab M, Anantharamaiah GM, Reddy ST, Van Lenten BJ, Datta G, Garber D, Fogelman AM. PMID: 15529023.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansAnimalsCells
    93. D-4F, an apolipoprotein A-I mimetic peptide, inhibits the inflammatory response induced by influenza A infection of human type II pneumocytes. Circulation. 2004 Nov 16; 110(20):3252-8. Van Lenten BJ, Wagner AC, Navab M, Anantharamaiah GM, Hui EK, Nayak DP, Fogelman AM. PMID: 15533864.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansCells
    94. Antiinflammatory properties of HDL. Circ Res. 2004 Oct 15; 95(8):764-72. Barter PJ, Nicholls S, Rye KA, Anantharamaiah GM, Navab M, Fogelman AM. PMID: 15486323.
      View in: PubMed   Mentions: 321     Fields:    Translation:HumansCells
    95. Genetic basis of atherosclerosis: part II: clinical implications. Circulation. 2004 Oct 05; 110(14):2066-71. Lusis AJ, Fogelman AM, Fonarow GC. PMID: 15466657.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansAnimalsCells
    96. Genetic basis of atherosclerosis: part I: new genes and pathways. Circulation. 2004 Sep 28; 110(13):1868-73. Lusis AJ, Fogelman AM, Fonarow GC. PMID: 15451808.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansAnimals
    97. Potential role for mitogen-activated protein kinase phosphatase-1 in the development of atherosclerotic lesions in mouse models. Arterioscler Thromb Vasc Biol. 2004 Sep; 24(9):1676-81. Reddy ST, Nguyen JT, Grijalva V, Hough G, Hama S, Navab M, Fogelman AM. PMID: 15242861.
      View in: PubMed   Mentions: 12     Fields:    Translation:AnimalsCells
    98. Oral D-4F causes formation of pre-beta high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice. Circulation. 2004 Jun 29; 109(25):3215-20. Navab M, Anantharamaiah GM, Reddy ST, Hama S, Hough G, Grijalva VR, Wagner AC, Frank JS, Datta G, Garber D, Fogelman AM. PMID: 15197147.
      View in: PubMed   Mentions: 109     Fields:    Translation:HumansAnimalsCells
    99. The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL. J Lipid Res. 2004 Jun; 45(6):993-1007. Navab M, Ananthramaiah GM, Reddy ST, Van Lenten BJ, Ansell BJ, Fonarow GC, Vahabzadeh K, Hama S, Hough G, Kamranpour N, Berliner JA, Lusis AJ, Fogelman AM. PMID: 15060092.
      View in: PubMed   Mentions: 150     Fields:    Translation:HumansAnimalsCells
    100. Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment. Circulation. 2003 Dec 02; 108(22):2751-6. Ansell BJ, Navab M, Hama S, Kamranpour N, Fonarow G, Hough G, Rahmani S, Mottahedeh R, Dave R, Reddy ST, Fogelman AM. PMID: 14638544.
      View in: PubMed   Mentions: 175     Fields:    Translation:HumansCellsCTClinical Trials
    101. Crosstalk between LXR and toll-like receptor signaling mediates bacterial and viral antagonism of cholesterol metabolism. Mol Cell. 2003 Oct; 12(4):805-16. Castrillo A, Joseph SB, Vaidya SA, Haberland M, Fogelman AM, Cheng G, Tontonoz P. PMID: 14580333.
      View in: PubMed   Mentions: 137     Fields:    Translation:AnimalsCells
    102. Oral synthetic phospholipid (DMPC) raises high-density lipoprotein cholesterol levels, improves high-density lipoprotein function, and markedly reduces atherosclerosis in apolipoprotein E-null mice. Circulation. 2003 Oct 07; 108(14):1735-9. Navab M, Hama S, Hough G, Fogelman AM. PMID: 14504179.
      View in: PubMed   Mentions: 6     Fields:    Translation:AnimalsCells
    103. Human apolipoprotein AI mimetic peptides for the treatment of atherosclerosis. Curr Opin Investig Drugs. 2003 Sep; 4(9):1100-4. Navab M, Anantharamaiah GM, Reddy ST, Van Lenten BJ, Hough G, Wagner A, Nakamura K, Garber DW, Datta G, Segrest JP, Hama S, Fogelman AM. PMID: 14582455.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimals
    104. ATP-binding cassette transporter 1 participates in LDL oxidation by artery wall cells. Arterioscler Thromb Vasc Biol. 2002 Nov 01; 22(11):1877-83. Reddy ST, Hama S, Ng C, Grijalva V, Navab M, Fogelman AM. PMID: 12426219.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    105. Influenza infection promotes macrophage traffic into arteries of mice that is prevented by D-4F, an apolipoprotein A-I mimetic peptide. Circulation. 2002 Aug 27; 106(9):1127-32. Van Lenten BJ, Wagner AC, Anantharamaiah GM, Garber DW, Fishbein MC, Adhikary L, Nayak DP, Hama S, Navab M, Fogelman AM. PMID: 12196340.
      View in: PubMed   Mentions: 42     Fields:    Translation:AnimalsCells
    106. Oxidized lipids as mediators of coronary heart disease. Curr Opin Lipidol. 2002 Aug; 13(4):363-72. Navab M, Hama SY, Reddy ST, Ng CJ, Van Lenten BJ, Laks H, Fogelman AM, Ready ST. PMID: 12151851.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansAnimalsCells
    107. Identification of genes induced by oxidized phospholipids in human aortic endothelial cells. Vascul Pharmacol. 2002 Apr; 38(4):211-8. Reddy ST, Grijalva V, Ng C, Hassan K, Hama S, Mottahedeh R, Wadleigh DJ, Navab M, Fogelman AM. PMID: 12449017.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    108. Oral administration of an Apo A-I mimetic Peptide synthesized from D-amino acids dramatically reduces atherosclerosis in mice independent of plasma cholesterol. Circulation. 2002 Jan 22; 105(3):290-2. Navab M, Anantharamaiah GM, Hama S, Garber DW, Chaddha M, Hough G, Lallone R, Fogelman AM. PMID: 11804981.
      View in: PubMed   Mentions: 133     Fields:    Translation:AnimalsCells
    Alan's Networks
    Concepts (495)
    Derived automatically from this person's publications.
    _
    Co-Authors (33)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _